Caris Life Sciences, Inc.
32.00USD
+0.2900 (+0.91%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CAI.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.02▼ | $0.04 | 3 | 6 |
| Next quarter | $0.11▲ | $0.07 | 7 | 1 |
| Current year | $0.14▲ | $0.13 | 0 | 2 |
| Next year | $0.37▲ | $0.36 | 2 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.01 | $0 | -0.01 (-100.0%) |
| 2026-03-31 | -$0.02 | $0 | +0.02 (+100.0%) |
| 2025-12-31 | $0.1 | $0.28 | +0.18 (+168.7%) |
| 2025-09-30 | -$0.14 | $0.08 | +0.22 (+158.8%) |
31 ratings from 12 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Hold | $22 $30 | Oct 19, 2026 |
| JP Morgan | Maintained | Overweight | $25 $35 | Oct 14, 2026 |
| TD Cowen | Maintained | Buy | $30 $36 | Oct 13, 2026 |
| UBS | Initiated | Neutral | $28 | Sep 9, 2026 |
| Evercore ISI Group | Maintained | Outperform | $25 $26 | Aug 6, 2026 |
| BTIG | Maintained | Buy | $32 $33 | Aug 6, 2026 |
| JP Morgan | Maintained | Overweight | $30 $25 | Aug 5, 2026 |
| Evercore ISI Group | Maintained | Outperform | $30 $25 | Jul 6, 2026 |
| BTIG | Reiterated | Buy | $32 | Jul 2, 2026 |
| Citigroup | Maintained | Buy | $35 $28 | May 8, 2026 |
| JP Morgan | Maintained | Overweight | $35 $30 | May 8, 2026 |
| BTIG | Maintained | Buy | $38 $32 | May 8, 2026 |
| Jefferies | Initiated | Buy | $28 | Apr 13, 2026 |
| Piper Sandler | Initiated | Neutral | $21 | Apr 10, 2026 |
| Evercore ISI Group | Maintained | Outperform | $34 $30 | Apr 6, 2026 |
| Canaccord Genuity | Maintained | Hold | $30 $22 | Mar 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $38 $34 | Feb 27, 2026 |
| Baird | Maintained | Outperform | $26 $28 | Feb 27, 2026 |
| BTIG | Maintained | Buy | $45 $38 | Feb 27, 2026 |
| Baird | Initiated | Outperform | $26 | Feb 17, 2026 |
| Canaccord Genuity | Maintained | Hold | $28 $30 | Dec 22, 2025 |
| Canaccord Genuity | Initiated | Hold | $28 | Dec 2, 2025 |
| Guggenheim | Maintained | Buy | $32 $36 | Aug 13, 2025 |
| Evercore ISI Group | Maintained | Outperform | $33 $40 | Aug 13, 2025 |
| Citigroup | Maintained | Buy | $34 $42 | Aug 13, 2025 |
51 filings from 19 insiders · 13 buy / 3 sell over 6m
Officers and directors of CAI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Denton John RusselOfficer, See Remarks | Sell | 7.5k | $31.82 | $239k | Sep 22, 2026 |
| Brille Brian JDirector; Officer, See Remarks | ExerciseStock Option | 400.0k | — | — | Sep 17, 2026 |
| Brille Brian JDirector; Officer, See Remarks | Sell | 400.0k | $30.33 | $12.13M | Sep 17, 2026 |
| Brille Brian JDirector; Officer, See Remarks | Exercise | 400.0k | $2.44 | $976k | Sep 17, 2026 |
| SPETZLER DAVID BAXLEY PH.D.President | Exercise | 1.25M | $2.44 | $3.05M | Sep 4, 2026 |
| SPETZLER DAVID BAXLEY PH.D.President | Sell | 597.2k | $24.76 | $14.83M | Sep 4, 2026 |
| FREDRICKSON DAVID PAULDirector | Grant | 13.2k | — | — | Aug 14, 2026 |
| PHILLIPS T DANNYDirector | Grant | 13.2k | — | — | Aug 14, 2026 |
| HALBERT JON S.Director | Grant | 13.2k | — | — | Aug 14, 2026 |
| JOHANSEN LAURA I.Director | Grant | 13.2k | — | — | Aug 14, 2026 |
| MINOR LLOYD B.Director | Grant | 13.2k | — | — | Aug 14, 2026 |
| VACIRCA JEFF LDirector | Grant | 13.2k | — | — | Aug 14, 2026 |
| GILLIAM JOSEPH E.Director | Grant | 13.2k | — | — | Aug 14, 2026 |
| CASTLEMAN PETER MDirector | Grant | 13.2k | — | — | Aug 14, 2026 |
| KNOWLES JONATHAN KENNETH CHARLESDirector | Grant | 1.6k | $15.62 | $25k | May 29, 2026 |
| POSTE GEORGE HDirector | Grant | 1.6k | $15.62 | $25k | May 29, 2026 |
| VACIRCA JEFF LDirector | Buy | 31.1k | $16.15 | $501k | May 11, 2026 |
| SPETZLER DAVID BAXLEY PH.D.President | Grant | 83.2k | — | — | Mar 6, 2026 |
| POWER LUKE THOMASChief Financial Officer | Grant | 64.0k | — | — | Mar 6, 2026 |
| DENTON JOHN RUSSELGeneral Counsel | Grant | 64.0k | — | — | Mar 6, 2026 |
No analyst notes on CAI yet.
Members whose judged calls on CAI have played out most reliably.
No settled calls on CAI yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
13 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 9 | 4 | 0 | 0 | Buy2.21 |
| 1 mo ago | 1 | 9 | 4 | 0 | 0 | Buy2.21 |
| 2 mo ago | 1 | 9 | 3 | 0 | 0 | Buy2.15 |
| 3 mo ago | 1 | 9 | 3 | 0 | 0 | Buy2.15 |